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Abstract
Background: In individual living cells p53 has been found to be expressed in a series of discrete
pulses after DNA damage. Its negative regulator Mdm2 also demonstrates oscillatory behaviour.
Attempts have been made recently to explain this behaviour by mathematical models but these
have not addressed explicit molecular mechanisms. We describe two stochastic mechanistic
models of the p53/Mdm2 circuit and show that sustained oscillations result directly from the key
biological features, without assuming complicated mathematical functions or requiring more than
one feedback loop. Each model examines a different mechanism for providing a negative feedback
loop which results in p53 activation after DNA damage. The first model (ARF model) looks at the
mechanism of p14ARF which sequesters Mdm2 and leads to stabilisation of p53. The second model
(ATM model) examines the mechanism of ATM activation which leads to phosphorylation of both
p53 and Mdm2 and increased degradation of Mdm2, which again results in p53 stabilisation. The
models can readily be modified as further information becomes available, and linked to other
models of cellular ageing.
Results: The ARF model is robust to changes in its parameters and predicts undamped oscillations
after DNA damage so long as the signal persists. It also predicts that if there is a gradual
accumulation of DNA damage, such as may occur in ageing, oscillations break out once a threshold
level of damage is acquired. The ATM model requires an additional step for p53 synthesis for
sustained oscillations to develop. The ATM model shows much more variability in the oscillatory
behaviour and this variability is observed over a wide range of parameter values. This may account
for the large variability seen in the experimental data which so far has examined ARF negative cells.
Conclusion: The models predict more regular oscillations if ARF is present and suggest the need
for further experiments in ARF positive cells to test these predictions. Our work illustrates the
importance of systems biology approaches to understanding the complex role of p53 in both ageing
and cancer.
Background
The p53 tumour suppressor plays a major role in cancer,
as evidenced by frequent TP53 gene mutations in human
tumours [1] and by the high incidence of cancer in Li-
Fraumeni individuals carrying germline mutations in the
TP53  gene [2]. There is a growing consensus that p53
plays an important role in ageing and limitations to
lifespan (reviewed in Bauer and Helfand (2006) [3] and in
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Papazoglu and Mills (2007) [4]) but this assertion has
been recently challenged on evolutionary grounds [5].
The TP53 gene encodes a transcription factor with target
genes that are involved in DNA repair, cell cycle arrest and
apoptosis. It has been described as the 'guardian of the
genome' [6], blocking cell cycle progression to allow the
repair of damaged DNA. It has also been described as a
'gatekeeper' [7-9] that dictates the fate of cells that have
suffered stress by directing them into irreversible path-
ways of senescence or apoptosis [10]. Figure 1 shows part
of the p53 signalling pathway which is a simplification of
the KEGG pathway [11]. Under normal homeostatic con-
ditions the cellular levels of p53 protein are kept at a low
level. There is basal transcription of the p53 gene even in
unstressed cells but the protein product does not accumu-
late as it has a short half-life (about 15–30 minutes) [12]
and is usually bound to Mdm2, an ubiquitin E3 ligase,
which targets p53 to the proteasome for degradation
[13,14]. Mdm2-binding prevents the transcriptional activ-
ity of p53 [15], a phenomenon that is dependent on the
catalytic activity of Mdm2 [16]. Mdm2 also has a short
half-life and is a substrate of its own E3 ligase activity in
vitro [17]. The degradation of a knocked-in RING finger
mutant of Mdm2 indicates the presence of an as-yet uni-
dentified cellular E3 ligase that ubiquitinates Mdm2 in
vivo [18]. The transcription of Mdm2 is regulated by p53
[19] and so under normal conditions, levels of both p53
and Mdm2 are kept at low levels.
It is well known that stress induces an increase in levels of
p53 which in turn leads to an increase in the transcription
of Mdm2 [20]. One pathway for stabilization of p53 is via
the kinase ATM, which is activated by DNA damage and
phosphorylates p53 close to its Mdm2 binding site, so
blocking its interaction with Mdm2 [9]. In addition, ATM
phosphorylates Mdm2 which not only interferes with its
ability to bind to p53 but also enhances the degradation
of Mdm2 [21,22] providing an additional route for p53
stabilization. Another mechanism for the increase in p53
levels is the activation of ARF (known as p14ARF  in
humans), a nucleolar protein that senses DNA damage
[23]. It has been shown that DNA damage disrupts the
interaction of ARF with the nucleolar protein B23 (nucle-
ophosmin) releasing ARF into the nucleoplasm so that it
can bind to Mdm2 [24]. ARF binding enhances the degra-
dation of Mdm2, resulting in p53 stabilisation [23,25].
ARF also responds to aberrant growth signals which are
triggered by oncogenes such as Ras or Myc, although the
induction of genes from the INK4a/ARF locus displays
species-specific variations [26]. Since an increase in p53
leads to an increase in Mdm2 transcription, and Mdm2
targets p53 for degradation, p53 levels are again inhibited,
providing a negative feedback loop. Negative feedback
loops have been found in several systems of interacting
proteins (e.g. Hes1 in Notch signalling [27], NF-kB signal-
ling system [28]) and have attracted the attention of math-
ematical modellers. In particular, models have been
produced to analyse the oscillations of p53 and Mdm2 in
previously published single-cell fluorescent reporter
assays [29-34]. The single cell assays have been very
informative, revealing that increasing DNA damage
results in an increased number of oscillations, but not an
increased magnitude in the response [30,35]. The data
also show that there is large intercellular variation with a
fraction of cells showing no response or a slowly fluctuat-
ing signal. In the cells in which oscillations were detected,
there was a wide fluctuation in the amplitude (about
70%) and smaller variations in the period of the peaks
(about 20%) [30]. The oscillations in these data showed a
period of about 5.5 hours with a delay of about 2 hours
between p53 and Mdm2 peaks (Figure 2, which is a repro-
Network diagram of the p53 signalling pathway Figure 1
Network diagram of the p53 signalling pathway. Adapted from the KEGG signalling pathway [11].BMC Systems Biology 2008, 2:75 http://www.biomedcentral.com/1752-0509/2/75
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Prolonged oscillations in the nuclear levels of fluorescently tagged p53 and Mdm2 in individual MCF7, U280 cells following  gamma irradiation Figure 2
Prolonged oscillations in the nuclear levels of fluorescently tagged p53 and Mdm2 in individual MCF7, U280 cells following 
gamma irradiation. Reproduced with permission from Geva-Zatorsky et al. 2006, Molecular Systems Biology [30]. A. Time-
lapse fluorescence images of one cell over 29 h after 5 Gy of gamma irradiation. Nuclear p53-GFP and Mdm2-YFP are imaged 
in green and red, respectively. Time is indicated in hours. B. Normalised nuclear fluorescence levels of p53-CFP (green) and 
Mdm2-YFP (red) following gamma irradiation. Top left: the cell shown in panel A. Other panels: five cells from one field of 
view, after exposure to 2.5 Gy gamma irradiation.BMC Systems Biology 2008, 2:75 http://www.biomedcentral.com/1752-0509/2/75
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duction of figure 1 from Geva-Zatorsky et al. [30] with
permission from the publisher).
All previous models to date have used a deterministic
approach to analyse the oscillatory behaviour. These
models have used differential equations and mathemati-
cal functions requiring a fairly large number of parameters
with the generation of oscillations being very dependent
on the range of parameter values chosen. Geva-Zatorsky et
al. [30] constructed six different models and found that
the simplest model, which contained one intermediary
and one negative feedback loop with a delay, was unable
to produce multiple oscillations and that it was necessary
to either introduce a positive feedback loop or a time
delay term (See figure 6 of Geva-Zatorsky et al. [30]).
However, these additions were not sufficient for robust-
ness over a wide range of parameter values. The addition
of a non-linear negative feedback loop, a linear positive
feedback loop or a second negative feedback loop pro-
duced models that were able to demonstrate sustained
oscillations over a wide range of parameters. As the mod-
els are deterministic, the outcome only depends on the
initial conditions and so they cannot be used to investi-
gate cell-cell variability. Geva-Zatorsky et al. [30] incorpo-
rated some random noise in protein production in their
models and found that the introduction of low-frequency
noise resulted in variability in the amplitude of the oscil-
lations as observed experimentally. Ma et al. [32] also
incorporated a stochastic component for the DNA dam-
age component of their model which resulted in variabil-
ity in the number of oscillations. However, for a dose of
2.5 Gy, they found that the majority of cells had only one
peak and that a step input of DNA damage was required
to obtain sustained oscillations.
The deterministic models have been useful in showing
that sustained oscillations can be produced in a system
where there is at least one negative feedback loop with a
delay, and a sustained signal. The signal represents dam-
aged DNA which triggers the cellular response as long as
the DNA damage persists [36]. It has also been shown that
stochasticity in protein production rates and DNA dam-
age events can explain some of the variability in the data.
However, in cellular systems, there will be random effects
on all processes. Most of the previous models ignored the
fact that p53 has to bind to Mdm2 for its Mdm2-depend-
ent degradation and that it is transcriptionally inactive
when bound. Instead, the models assumed that p53 deg-
radation depended on total Mdm2 levels regardless of
whether Mdm2 was bound to p53 or not. Since the regu-
lation of p53 is dependent on its interaction with Mdm2,
we would expect that the oscillatory behaviour of the sys-
tem would be strongly affected by the binding affinity of
Mdm2 to p53. Therefore any mechanistic model of the
system should include the Mdm2-p53 complex.
Other disadvantages of the current models are that they
cannot be easily modified or linked to other models and
they are not very accessible to non-mathematicians. Most
importantly, the majority of previous models have not
clearly demonstrated how the biological mechanisms of
the system contribute to the oscillatory behaviour. The
deterministic models of Ma et al. 2005 [32], Ramalingam
et. al 2007 [37] and Ciliberto et al 2005 [29] are based on
molecular mechanisms but none of these are really suita-
ble for a stochastic approach, since the Gillespie algo-
rithm assumes mass action kinetics and these models
contain Hill or Michaelis-Menten functions in their rate
laws. We chose to build the simplest possible stochastic
model using a mechanistic approach that would be partic-
ularly relevant to biologists (see Figure 2 and Methods).
The aims of building a stochastic mechanistic model are
three-fold. First, we wanted to see if a simple model with
stochastic effects would produce sustained oscillations
without the need to introduce additional feedback loops
or non-linear functions. Second, we wanted the model to
be based on the mechanisms that have been proposed by
biologists and could be easily understood by the non-
mathematically inclined. Third, we wanted to build a
model that can be easily incorporated into a larger model
such as our earlier model of the ubiquitin-proteasome sys-
tem [38]. In order to achieve these objectives we used the
Systems Biology Markup Language (SBML) [39]. SBML is
a well-known modelling standard, allowing models to be
shared in a form that other researchers can use even in a
different software environment. Since both ATM and ARF
activation have been proposed as mechanisms for stabil-
ising p53 after DNA damage, we developed two inde-
pendent models to see whether oscillations would result
from either of these mechanisms. The ARF model is sim-
pler, and so we introduce this model first and show how
it can be modified to produce the ATM model.
There are many tools available for creating and running
SBML models (see http://www.sbml.org). We chose to use
the Biology of Ageing e-Science Integration and Simula-
tion system (BASIS) [40,41] to store the models, run sim-
ulations and store results. The advantage of this system is
that it is user friendly, it can be freely accessed by a web
browser, and allows easy sharing of models.
Results
(1) ARF Model
Small oscillations are not distinguishable from white noise under 
normal conditions
The full list of species and reactions for the ARF model are
listed in Tables 1 and 2 respectively. Figure 3 shows a dia-
gram of the system (full details are given in the methods
section). Even under normal conditions, there is synthesis
and degradation of both p53 and Mdm2 so that we mightBMC Systems Biology 2008, 2:75 http://www.biomedcentral.com/1752-0509/2/75
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expect low level oscillations of both proteins. However,
since we have used a stochastic simulator, there is also a
large component of white noise due to protein synthesis
and degradation being modelled as random processes and
this would mask any oscillatory effects (Figure 4). The
autocorrelation function (ACF) for p53 was computed
and plotted using the R statistical package. A periodic ACF
is consistent with oscillations whereas a non-periodic ACF
is consistent with noise. The ACF confirms that most of
the oscillatory behaviour in the model is due to white
noise but there are some regular oscillations in the second
simulation (see Figure 5, top row, 2nd column). The auto-
correlation function for Mdm2 showed similar behaviour
and so the plots are not shown.
One intermediary in a negative feedback loop and sustained damage 
is sufficient to produce oscillatory behaviour
We started by building the model without any intermedi-
ary species so that Mdm2 synthesis only depended on the
level of unbound p53. This model did not predict sus-
tained oscillations after induction of DNA damage (data
not shown). The addition of one intermediary,
Mdm2_mRNA, in the negative feedback loop was suffi-
cient for the appearance of sustained oscillations, in both
p53 and Mdm2, confirming that a delay is required (Fig-
ure 6). Mdm2_mRNA represents the messenger RNA mol-
ecule which is transcribed from the Mdm2 gene and
carries the coding information to the site of protein syn-
thesis. The autocorrelation function shows that these
oscillations are distinct from those generated by white
noise (Figure 7). The model output shows that there is
intercellular variability as seen in the data. In particular,
although most simulations resulted in 5 or 6 peaks in a 30
hour period, there were occasional simulated "cells" with
4 or less peaks. There is also intracellular variability in the
oscillation amplitude but much less variation in the oscil-
lation period which was about 5.5 hours. The model pre-
dictions regarding the oscillation period agrees with the
Diagram of the system for the ARF model Figure 3
Diagram of the system for the ARF model. Details of the reactions are in Table 2. IR is activated under conditions of irradiation 
at time t = 1 hour and then deactivated again 1 minute later. The numbers on the arrows refer to the reaction numbers in 
Table 2.BMC Systems Biology 2008, 2:75 http://www.biomedcentral.com/1752-0509/2/75
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experimental data [30] as expected, since the parameters
which affect the period are well known (see Table 3). The
agreement of the model predictions with the data, regard-
ing intracellular and intercellular variability, confirms
that a stochastic approach is appropriate for this system.
Predictions when the efficiency of protein degradation is reduced
Since it is known that proteasomal activity declines with
age [42], and in tissues such as the rodent cerebral cortex,
the age-related loss of chymotryptic proteasomal activity
is significant (40%, as reported by Zeng et al [43]), we
decided to test the effect of reduced degradation by scaling
all the parameters for protein degradation by the same fac-
tor (kdegp53, kdegMdm2, kdegARF, kdegARFMdm2). The model pre-
dicted that decreasing protein degradation efficiency by
up to 30% had little effect, but larger decreases resulted in
lengthening the oscillation period. If protein degradation
efficiency was less than 50%, then the levels of both
Mdm2 and p53 increased rapidly after DNA damage and
the values oscillated about a mean value of about 350 for
Six simulations of the ARF model under normal conditions (no irradiation) Figure 4
Six simulations of the ARF model under normal conditions (no irradiation).BMC Systems Biology 2008, 2:75 http://www.biomedcentral.com/1752-0509/2/75
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p53 and 400 for Mdm2 (instead of about 250 and 200
respectively), although the amplitude of the peaks was
similar (data not shown).
Effect of changing the amount of damage
To simulate the effect of varying the dose of gamma irra-
diation, we changed the level that the species IR was
increased after the irradiation event in the model. The
default value of 25 dGy corresponds to a dose of 2.5 Gy.
We used units of dGy, rather than Gy, in our model, as it
is necessary to use integer numbers for stochastic simula-
tion. The effect of increasing this to 50 dGy (i.e. 5 Gy) had
no effect on the oscillation period and little effect on the
amplitude, however there were no cells with less than 4
peaks, as was the case in the default model. Conversely,
decreasing the value of IR after irradiation led to fewer
cells with oscillations. Therefore our model agrees with
the experimental observation that increasing irradiation
The p53 autocorrelation function (ACF) for the six simulations under normal conditions shown in Figure 4 Figure 5
The p53 autocorrelation function (ACF) for the six simulations under normal conditions shown in Figure 4. (The ACF for 
Mdm2 was very similar and so not shown.)BMC Systems Biology 2008, 2:75 http://www.biomedcentral.com/1752-0509/2/75
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dose produces more peaks but does not affect the oscilla-
tion period. However, our model predicts a slight decrease
in the amplitude of the peaks at low irradiation doses (IR
= 1 dGy).
Effect of a gradual increase in DNA damage from oxidative stress
During ageing there is a gradual increase in damaged DNA
due to either an increase in oxidative stress and/or a
decrease in anti-oxidant capacity. We used our model to
see if oscillations would occur in this scenario. To simu-
late the effect of a gradual increase in DNA damage we
introduced a species called ROS (reactive oxygen species)
into the model and changed the reaction for DNA damage
so that it depended on the level of ROS instead of IR. We
set the rate law for DNA damage reaction so that it gradu-
ally increased over time. We also added an event at time
Table 1: List of species for the ARF model
Name Description Database term Initial amount
p53 Unbound p53 protein P04637 5
Mdm2 Unbound Mdm2 protein Q00987 5
Mdm2_p53 Mdm2/p53 complex P04637/Q00987 95
Mdm2_mRNA Mdm2 messenger RNA SBO:0000278 0
ARF Unbound ARF protein Q8N726 0
ARF_Mdm2 ARF/Mdm2 complex Q8N726/Q00987 0
IR Dose of irradiation n/a 0 dGy
damDNA Amount of damaged DNA CHEBI16991 0
Terms starting with:
P or Q are from UniProtKB/Swiss-Prot [61].
SBO are from Systems Biology Ontology [62]
CHEBI are from Chemical Entities of Biological Interest Database [63]
Table 2: List of reactions for the ARF model
Reac No.a Name Term Kinetic law Parameter valuesb
1 p53 synthesis GO:0006412 ksynp53 7.8E-2 mol s-1 Based on p53 half-life ~20 min 
[12].
2 p53/Mdm2 binding GO:0002039 kbinMdm2p53<#p53><#Mdm2> 1.155E-3 mol-1 s-1 Assumed that 95% of p53 is 
bound to Mdm2 under normal 
conditions.
3 Mdm2_p53 dissociation GO:0043624 krelMdm2p53 <#Mdm2_p53> 1.155E-5 s-1 Based on dissociation constant 
of ~100 molecules [56].
4 p53 degradation GO:0043161 kdegp53<#Mdm2_p53> 8.25E-4 s-1 p53 half-life ~20 min [12].
5 Mdm2 Transcription GO:0003700 ksynMdm2mRNA<#p53> 1.0E-4 s-1 Turnover of Mdm2_mRNA was 
adjusted to give period of 
oscillations ~5–6 h [35].
6 Mdm2_mRNA degradation GO:0006402 kdegMdm2mRNA<#Mdm2_mRNA> 1.0E-4 s-1
7 Mdm2 synthesis GO:0006412 ksynMdm2<#Mdm2_mRNA> 4.95E-4 s-1 Based on Mdm2 half-life ~30 
min [12].
8 Mdm2 degradation GO:0043161 kdegMdm2<#Mdm2> 4.33E-4 s-1 Mdm2 half-life ~30 min [12].
9 DNA damage GO:0006974 kdam<#IR> 8.0E-2 s-1 Based on about 30 double 
strand breaks per cell per Gy 
irradiation [64].
10 DNA repair GO:0006281 krepair<#damDNA> 2.0E-5 s-1 This was set so that all DNA 
damage was repaired by ~10–
16 h[65].
11 ARF activation GO:0030330 kactARF<#damDNA> 3.3E-5 s-1 ARF is activated within 1 hour 
of DNA damage and activity 
peaks at 6 h.
12 ARF/Mdm2 binding GO:0005515 kbinARFMdm2<#ARF><#Mdm2> 1.0E-2 mol-1 s-1 This was set so that ARF/Mdm2 
complexes peaks at 6–8 h after 
IR [23].
13 ARF degradation GO:0043161 kdegARF<#ARF> 1.0E-4 s-1 Based on ARF half-life ~6 h 
[66].
14 ARF-dependent Mdm2 
degradation
GO:0043161 kdegARFMdm2<# ARF_Mdm2> 1.0E-3 s-1 Assumed to be 3-fold faster 
than normal degradation 7[25].
aReaction numbers correspond to the numbered arrows in Figure 3, bmol refers to the number of moleculesBMC Systems Biology 2008, 2:75 http://www.biomedcentral.com/1752-0509/2/75
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40 hours to increase the repair capacity to see if the oscil-
lations would die down after DNA damage is repaired.
The model predicts that oscillations appear when DNA
damage starts to accumulate and then remain even after
DNA damage is repaired, although the amplitude
decreases over time (Figure 8). The persistence of the oscil-
lations is due to the slow turnover of ARF. If we increase
the degradation rate of ARF, then the oscillations die out
more quickly (data not shown). Our simulations suggest
that it is not necessary to have a sudden increase in dam-
age in order to trigger spontaneous oscillations.
Effect of varying model parameters
We varied each of the model parameters to test the robust-
ness of the model and to see which parameters affected
the oscillatory behaviour. The results are summarised in
Table 3. The model is robust to small changes in the
parameter values (either two-fold decrease or two-fold
increase) and even ten-fold changes in some of the param-
Six simulations for the ARF model under conditions of irradiation (IR = 25 dGy for 1 minute at time t = 1 hour) Figure 6
Six simulations for the ARF model under conditions of irradiation (IR = 25 dGy for 1 minute at time t = 1 hour).BMC Systems Biology 2008, 2:75 http://www.biomedcentral.com/1752-0509/2/75
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eters did not result in loss of oscillatory behaviour. The
changes which did result in loss of oscillations were in the
parameters that affected DNA damage, either because
there was not enough damage to produce oscillations, or
it was removed too quickly to sustain the damage signal.
An increase in the turnover rate of p53, Mdm2 or
Mdm2_mRNA (the intermediary) resulted in a reduction
in the oscillation period. Conversely, a decrease in these
parameters resulted in an increase in the oscillation
period. No other parameters had any significant effect on
the period. We conclude that the oscillation period is very
dependent on the turnover rates of p53 and Mdm2. An
increase in the turnover of p53 resulted in an increase in
the oscillation amplitude, whereas an increase in the turn-
over of Mdm2 or Mdm2_mRNA, or in the binding affinity
of Mdm2 to p53 resulted in a decrease in the amplitude.
The increase in amplitude due to increased p53 turnover
is expected, since an increase in protein synthesis enables
The p53 autocorrelation function (ACF) for the six simulations of irradiated cells as shown in Figure 6 Figure 7
The p53 autocorrelation function (ACF) for the six simulations of irradiated cells as shown in Figure 6. (The ACF for Mdm2 
was very similar and so not shown.)BMC Systems Biology 2008, 2:75 http://www.biomedcentral.com/1752-0509/2/75
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p53 (and consequently Mdm2), to reach higher levels
before the feedback kicks in to limit its abundance. An
increase in the binding affinity of Mdm2 to p53, results in
more p53 being targeted for degradation, which explains
the predicted decrease in amplitude. The predicted
decrease in amplitude due to an increase in the turnover
of Mdm2_mRNA is less intuitive but can be explained as
follows. An increase in the turnover of Mdm2_mRNA
increases the responsiveness of the system, resulting in a
more rapid increase in Mdm2_mRNA and hence Mdm2
protein synthesis following DNA damage. This increase in
Mdm2 leads to some restoration of p53/Mdm2 binding
and so p53 levels decrease and the oscillation amplitude
is thereby lowered.
(2) ATM Model
Variable oscillations after DNA damage
Figure 9 shows the part of the ATM model which differs
from the ARF model. We found that this model generally
produced one large initial peak of p53 after DNA damage,
followed by irregular oscillations in which p53 levels
remained relatively high (Figure 10).
Addition of p53_mRNA
The reaction for p53 synthesis was modified by adding in
a step for transcription so that p53 synthesis depended on
the level of p53_mRNA. The addition of this step resulted
in an increase in noise in p53 synthesis. The model now
predicts sustained oscillations with considerable intercel-
lular variability as seen in the experimental data (Figure
11).
Effect of varying model parameters
As for the ARF model we varied the parameters to see if the
oscillatory behaviour was sensitive to the changes in their
values. The model was fairly robust to parameter changes
for a decrease or increase by one order of magnitude. Sim-
ilar to the ARF model, a ten-fold decrease in p53 turnover
resulted in loss of oscillations. In the same way that the
rate of ARF activation had little effect on the model out-
come, varying the rate of ATM activation had no effect on
the period or amplitude of oscillations. Varying the
parameter for p53 phosphorylation, resulted in a longer
period and higher levels of p53 and Mdm2 when the rate
was increased ten-fold, but a ten-fold decrease had little
effect. The parameter for Mdm2 phosphorylation was
much more sensitive with a ten-fold increase leading to
loss of oscillations and a ten-fold decrease resulting in a
much lower amplitude.
Discussion
We have developed two simple stochastic models of the
p53/Mdm2 circuit that reflects biological reality with the
minimum of detail. We considered two different mecha-
nisms for the DNA damage response: ARF activation, fol-
lowed by sequestering of Mdm2, and ATM activation
Table 3: Summary of sensitivity analysis for the ARF model
Biological process Parameters changed Effect on period as parameter is increased 
(decreased)
Effect on amplitude as parameter is 
increased (decreased)
× 2 × 10 × 2 × 10
p53 turnover ksynp53, kdegp53 ↓ (↑) ↓ (oscillations lost) ↑ (↓) ↑ (oscillations lost)
Mdm2 turnover ksynMdm2, kdegMdm2 ↓ (↑) oscillations lost (↑) ↓ (↑) oscillations lost (↓)
Mdm2_mRNA turnover ksynMdm2mRNA
kdegMdm2mRNA
↓ (↑) ↓ (↑) ↓ (↑) ↓ (↑)
p53/Mdm2 binding and 
release
kbinMdm2p53, krelMdm2p53 ↔ (↔) ↔ (↔) ↓ (↑) ↓ (↑)
DNA damage kdam ↔ (↔) ↔ (↔) 
(Greater variability in period for 
×10 increase)
↔ (↔) ↑ (↓) 
(Very few cells with oscillations for 
×10 decrease)
DNA repair krepair ↔ (↔) ↔ (↔) ↓ (↑) ↓ (↑) 
(Very few cells with oscillations for 
×10 increase)
ARF activation kactARF ↔ (↔) ↔ (↔) ↑ (↓) ↑ (↓) 
(Very few cells with oscillations for 
×10 decrease)
ARF degradation kdegARF ↔ (↔) ↔ (↔) ↔ (↔) ↓ (↑)
ARF/Mdm2 binding kbinARFMdm2 ↔ (↔) ↔ (↔) ↔ (↓) ↔ (↓)
ARF-dependent Mdm2 
degradation
kdegARFMdm2 ↔ (↔) ↔ (↔) 
(Period is very irregular in both 
cases)
↔ (↓) ↔ (↓)
Key
↔ No change, ↓ Decrease in period or amplitude, ↑ Increase in period or amplitudeBMC Systems Biology 2008, 2:75 http://www.biomedcentral.com/1752-0509/2/75
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followed by phosphorylation of Mdm2 and p53. The rea-
son that we chose to model both mechanisms is to
encompass scenarios in which cells do or do not express
ARF. For some experiments H1299 human lung cancer
cells (which have been shown to be ARF positive [44])
may be utilized, but the current experimental data comes
from cells which do not express ARF [30].
We have started from the biology and built network mod-
els that incorporate biological mechanisms and then by
using SBML have converted these into discrete stochastic
models that can be simulated. Both models contain one
negative feedback loop and all the reactions contain rates
that are based on mass action kinetics. The first model was
based on the p14ARF mechanism of sequestering Mdm2
after DNA damage which has the effect of stabilising p53
Oscillations are triggered when DNA damage accumulates gradually over time and disappear when DNA is repaired (ARF  model) Figure 8
Oscillations are triggered when DNA damage accumulates gradually over time and disappear when DNA is repaired (ARF 
model). DNA damage starts to accumulate at time t = 0, and increases until t = 40 hours, when the rate of DNA repair is 
increased ten thousand-fold.BMC Systems Biology 2008, 2:75 http://www.biomedcentral.com/1752-0509/2/75
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and increasing its transcriptional activity. If there is sus-
tained DNA damage, this model produces oscillations
which closely match experimental data in terms of the
period, amplitude, intracellular variability between peaks
and intercellular variability. A common criticism of math-
ematical models is that they are very dependent on the
choice of parameter values particularly where values are
not available from experimental data but have to be esti-
mated by model fitting. However, in this model the
behaviour was robust to changes in the parameter values
and it predicted that oscillations were only lost when
there was insufficient or unsustained DNA damage, a ten-
fold decrease in p53 turnover or a ten-fold increase in
Mdm2 turnover. Only a few of the parameters affect the
period or amplitude of the oscillations, and these are
mainly the parameters involved with p53 and Mdm2
turnover. These are the parameters for which we have the
most certain information since the half-life of both p53
and Mdm2 is known to be approximately 20–30 minutes
[12].
Our model suggests that oscillations appear after DNA
damage due to the action of p14ARF binding to Mdm2.
This interferes with p53-Mdm2 binding and prevents p53
degradation, so that p53 levels are able to rise. This is fol-
lowed by a rise in Mdm2 and when pools of Mdm2 are
high, there is sufficient Mdm2 to allow p53 binding to
resume. This results in p53 levels decreasing, and with less
p53, levels of Mdm2 also start to decline. If pools of ARF
are still active when levels of Mdm2 are lowered, p53 is
prevented from binding to Mdm2 and the cycle begins
again. The oscillations continue as long as there is suffi-
cient p14ARF to compete with p53 for Mdm2 binding.
Therefore oscillations are only observed when there is a
Diagram showing part of the network that is changed for the ATM model Figure 9
Diagram showing part of the network that is changed for the ATM model.BMC Systems Biology 2008, 2:75 http://www.biomedcentral.com/1752-0509/2/75
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DNA damage signal. If p53 turnover is too slow, then p53
is unable to rise to sufficient levels to allow oscillations.
On the other hand if Mdm2 turnover is too rapid, then
there is always enough Mdm2 present to bind to p14ARF
and p53. Therefore our model predicts that the appear-
ance of oscillations is dependent on the relative amounts
of p53, Mdm2 and p14ARF present in the cell, and it might
be instructive to look at flow cytometric measurements of
these proteins. The predictions of our model are amena-
ble to experimental confirmation through genetic manip-
ulation of p53, Mdm2, and p14ARF levels within cells
exposed to DNA damage.
p53 is important for eliminating cells with irreparable
DNA damage to preclude the growth of tumours, but this
mechanism would not apply to postmitotic neurons; nev-
ertheless p53 oscillations may still result in neuronal loss.
There is evidence to suggest that loss of p53 improves the
outcome in models of the expanded polyglutamine disor-
ders Huntington's disease and spinocerebellar ataxia type
Six simulations for the ATM model under conditions of irradiation (IR = 25 dGy for 1 minute at time t = 1 hour) Figure 10
Six simulations for the ATM model under conditions of irradiation (IR = 25 dGy for 1 minute at time t = 1 hour).BMC Systems Biology 2008, 2:75 http://www.biomedcentral.com/1752-0509/2/75
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1 [45-47]. The accumulation of abnormal protein may
induce p53 oscillations through generation of ROS
[48,49]. Our simulations indicate that an age-related
accumulation of ROS may trigger p53/Mdm2 oscillations
at a time in life when proteasome efficiency is declining.
With regard to the brain (where the most dramatic decline
in proteasome activity has been documented [43,50-52])
it would therefore seem particularly important to under-
stand how oscillations are affected by alterations in the
ubiquitin/proteasome system.
The mechanism of p14ARF binding to Mdm2 has some
similarities with the ATM mechanism. ATM phosphor-
ylates Mdm2 and p53 which disrupts their ability to form
a complex. ATM also enhances the degradation of Mdm2.
Wagner et al used a deterministic model to show that ATM
Six simulations for the ATM model under conditions of irradiation (IR = 25 dGy for 1 minute at time t = 1 hour) with an addi- tional step for p53 synthesis Figure 11
Six simulations for the ATM model under conditions of irradiation (IR = 25 dGy for 1 minute at time t = 1 hour) with an addi-
tional step for p53 synthesis.BMC Systems Biology 2008, 2:75 http://www.biomedcentral.com/1752-0509/2/75
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induces oscillations by increasing feedback strength and
effective dampening [53].
The variability in the oscillations is due the stochastic
nature of the processes in the model, especially the
amount of DNA damage and the rate of its repair. We pro-
pose that this would account for the intercellular variabil-
ity in the number of peaks. Since the protein synthesis and
degradation is also inherently stochastic, the relative
amounts of p53, Mdm2, and p14ARF also vary with time
and we hypothesise that this accounts for the intracellular
variability in the oscillation amplitude.
Our models show that oscillations are very robust to
parameter changes when we assume that the mechanism
for p53 stabilization is via ARF. This shows that the close
agreement between model predictions and experimental
data is not a result of our choice of parameter values. In
fact most of the parameters are based on known values
and the parameters for which we were least confident had
the smallest effect on the model behaviour.
We also modified the model so that the mechanism for
p53 stabilization is phosphorylation by activated ATM.
We have found that a model based on this mechanism
requires an additional step for p53 synthesis and produces
very variable oscillations. The experimental data [30] also
shows large variations in the oscillatory behaviour and
since the MCF7 cells which were used did not express ARF,
our model agrees with the data. It would be interesting to
repeat the experiments carried out in Uri Alon's laboratory
on a cell line which expresses ARF to see if more regular
sustained oscillations are obtained. Our models may help
to explain why oscillations are only observed in certain
cell types.
We used stochastic simulation as this is the most natural
way to introduce the cellular variability which is seen
experimentally. Also some of the species, such as the
amount of DNA damage, have low values which necessi-
tate a stochastic approach.
In order to show that the variability in the oscillations is
qualitatively different from those seen in deterministic
simulations, we also performed deterministic simulations
on the models (Figures 12 and 13). In the ARF model,
oscillations are still produced but interestingly, the deter-
ministic version of the ATM model predicts only one peak
followed by fairly constant levels of total p53 and Mdm2
but at a level higher than the initial values. The lack of
oscillations may be either due to the averaging effect since
there is variability in the period in this model, or due to
the approximation used to derive the reaction rate equa-
tions in the deterministic simulation. We carried out 1000
repeat simulations of the stochastic ATM model and com-
pared the mean with the deterministic simulation. We
found that the plot of the mean was very similar to the
deterministic output, confirming that the lack of oscilla-
tions was due to the averaging effect (data not shown).
Therefore the stochastic model shows stochastic oscilla-
tions consistent with the data for single cell measure-
ments, whereas the deterministic model loses the
oscillations due to averaging out effects. The averaging
effect is due to the inter-cell variability in the oscillatory
period and although the cells are synchronised for the first
peak, they are unsynchronised for all the following peaks.
Therefore the oscillations in the different cells cancel out.
This is also observed experimentally if measurements are
taken for a population of cells rather than individual cells
[35].
Deterministic solution for the ARF model Figure 12
Deterministic solution for the ARF model.
Deterministic solution for the ATM model Figure 13
Deterministic solution for the ATM model.BMC Systems Biology 2008, 2:75 http://www.biomedcentral.com/1752-0509/2/75
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We are currently collaborating with members of Newcas-
tle School of Mathematics and Statistics to fit the model to
experimental data using new Bayesian calibration tech-
niques. This work will also shed more light on whether
the ARF or ATM mechanism is most likely to account for
the variability in the oscillatory behaviour.
SBML is a well known modelling standard that allows
models to be shared and easily modified as new data
emerges. The SBML code is available [see Additional file 1
for the ARF model and Additional file 2 for the ATM
model]. It can also be downloaded from the BASIS system
or the Biomodels database [41,54]. An additional advan-
tage of using SBML is that the model can be easily embed-
ded into a larger model of the ubiquitin-proteasome
system and linked to models of DNA damage and tel-
omere-dependent checkpoint pathways that are being
developed within the Centre for Integrated Systems Biol-
ogy of Ageing and Nutrition at Newcastle University. This
work is currently in progress.
Conclusion
We have developed models of the p53-Mdm2 circuit to
examine the cellular mechanisms that might contribute to
the variability in the pattern of sustained oscillations after
DNA damage. We considered that stabilisation of p53 can
occur either through activation of p14ARF or via activation
of ATM. The models predict more regular oscillations if
ARF is present and suggest the need for further experi-
ments in ARF positive cells to test these predictions. The
models were encoded in SBML to ensure that they can be
easily modified and extended as more data become avail-
able. Our work illustrates the importance of systems biol-
ogy approaches to understanding the complex role of p53
in both ageing and cancer.
Methods
Construction of network models
We assume that p53 is synthesised at a constant rate, and
that under normal conditions it is usually bound to
Mdm2 and then degraded. We assume that p53 is only
transcriptionally active when not bound to Mdm2, and so
the production of Mdm2_mRNA is dependent on the
pool of unbound p53. The synthesis of Mdm2 depends
on the level of Mdm2_mRNA and so is also dependent on
the level of unbound p53. Thus Mdm2_mRNA provides
the intermediary link between p53 and Mdm2 to provide
the necessary delay in the negative feedback loop. We also
include degradation of Mdm2 and Mdm2_mRNA.
To carry out a 'virtual experiment' whereby the cell is sub-
ject to irradiation, we use an SBML event structure in the
model so that after the simulation has been running for 1
hour (virtual time) the level of a species named IR goes up
from 0 to 25 dGy for 1 minute and then returns back to
zero. A reaction to mimic damage to DNA depends on the
level of IR and only occurs when IR > 0 dGy. A species
called damDNA keeps track of the amount of damaged
DNA in the cell. We assume that damaged DNA can be
repaired at rate krepair.
ARF model
The presence of damaged DNA activates ARF which
increases from zero with rate kactARF <# damDNA>, where
<#damDNA> denotes the number of damaged DNA mol-
ecules. We assume that ARF binds to Mdm2 with a higher
affinity than p53 and so levels of unbound p53 increase.
This results in an increase of p53 transcriptional activity
and so we predict an increase in levels of Mdm2_mRNA,
followed by an increase in Mdm2. Since it is known that
ARF increases the degradation rate of Mdm2, we assume
that Mdm2 which is bound to ARF is degraded at a higher
rate than normal. ARF is also degraded which allows the
damage signal to decline as the damaged DNA is repaired.
A graphical representation of the model is given in Figure
3. A list of all the components of the model (which we
refer to as 'species' using the terminology of SBML) is
given in Table 1. Note that the initial values for p53 and
Mdm2 refer to the number of unbound molecules and
that the majority of p53 is bound to Mdm2 in the
Mdm2_p53 complex. So initially we assume that there are
100 molecules of p53 and Mdm2. A list of all the interac-
tions between the species (termed 'reactions') and the
kinetic parameters involved in each reaction are shown in
Table 2.
ATM Model
The ATM model contains the same species as the ARF
model except that ARF and ARF_Mdm2 were removed
and five new species were added to represent p53_mRNA,
phosphorylated p53, phosphorylated Mdm2, and ATM in
its inactive and active form (see Table 4). The reactions
involving ARF were removed (i.e. reactions 11–14 of
Table 2 and replaced with reactions for phosphorylation
of p53 and Mdm2, ATM activation and inactivation, and
p53_mRNA turnover (see Table 5). We also modified the
step for p53 synthesis by adding in steps for transcription.
This addition to the model had the effect of adding addi-
tional noise to p53 synthesis.
Parameter Values
We used mass action kinetics for all the reaction rates [55].
The last column in Tables 2 and 5 gives details and refer-
ences for the chosen parameter values. Most of the param-
eter values were taken from the literature and we can be
fairly confident of their values. In particular we were con-
fident of the values of the parameters which had most
effect on the model behaviour such as p53 and Mdm2
turnover rates. The parameters that we were least confi-BMC Systems Biology 2008, 2:75 http://www.biomedcentral.com/1752-0509/2/75
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dent about were the rate of ARF binding to Mdm2 and the
rate of ARF-dependent Mdm2 degradation. However the
model was robust to changes in either of these parameters.
We chose default values for all the parameters involved in
p53 and Mdm2 turnover which would give a half-life of
about 20 minutes for p53 and 30 minutes for Mdm2
under normal conditions. The binding rate of p53 to
Mdm2 was set so that about 95% of the pool of p53 is
bound to Mdm2 under normal conditions and the disso-
ciation rate was set to 100 molecules which corresponds
to about 277 nM, assuming the cell volume to be 0.6 μm3.
This is within the range 60–700 nM suggested by experi-
mental measurements [56]. We then included the event
for stressing the cell and adjusted the parameter values for
Mdm2_mRNA turnover until we obtained a period of
about 5.5 hours for the oscillations and a delay of about 2
hours between the p53 and Mdm2 peaks. We carried out
sensitivity analysis by varying each parameter over a range
of ×0.1 to ×10.0 of the original value. In some cases we
varied combinations of parameters simultaneously, since
some of the parameters are not independent. For example,
we looked at varying the turnover rate of p53 and Mdm2
by varying the synthesis and degradation rates together, so
that the total levels of the proteins remained constant.
Model code and analysis of results
We used SBML to translate the graphical model into a
computer readable format. The model was first encoded
using SBML shorthand [55] and then translated into full
Table 4: Additional species for the ATM model. (ARF and ARF_Mdm2 were removed)
Name Description Database term Initial amount
p53_P Phosphorylated p53 P04637 0
Mdm2_P Phosphorylated Mdm2 Q00987 0
ATMI Inactive ATM Q13315 200
ATMA Active ATM Q13315 0
p53_mRNA p53 messenger RNA SBO:0000278 20
Terms starting with:
P or Q are from UniProtKB/Swiss-Prot [61]
SBO are from Systems Biology Ontology [62]
Table 5: List of changed and additional reactions for the ATM model
Reac No.a Name Term Kinetic law Parameter valuesb
1 p53 synthesis GO:0006412 ksynp53 <#p53_mRNA> 6.0E-3 s-1 Based on p53 half-life ~20 
min[12]
15 ATM activation GO:0006468 kactATM<#damDNA><#ATMI> 1.0E-4 mol-1 s-1 Phosphorylation takes place on 
time-scale of a few minutes. Rate 
of reaction depends on amount 
of damaged DNA and pool of 
ATMI.
16 ATM inactivation GO:0006470 kinactATM<#ATMA> 5.0E-4 s-1 De-phosphorylation is of the 
same order of magnitude as 
phosphorylation.
17 p53 phosphorylation GO:0006468 kphosp53 <#p53><#ATMA> 5.0E-4 mol-1 s-1 Phosphorylation takes place on 
time-scale of a few minutes.
18 p53 dephosphorylation GO:0006470 kdephosp53 <#p53_P> 5.0E-1 s-1 This parameter was varied to 
obtain oscillations.
19 Mdm2 Transcription GO:0003700 ksynMdm2mRNA<#p53_P> 1.0E-4 s-1 Same as ARF model
20 Mdm2 phosphorylation GO:0006468 kphosMdm2<#Mdm2><#ATMA> 2.0 mol-1 s-1 This is more rapid th.an 
phosphorylation of p53 by ATM 
[22].
21 Mdm2 de-phosphorylation GO:0006470 kdephosMdm2 <#Mdm2_P> 5.0E-1 s-1 De-phosphorylation is of the 
same order of magnitude as 
phosphorylation.
22 Mdm2 degradation enhanced 
by ATM
GO:0043161 kdegMdm2ATM<#Mdm2_P> 4.0E-4 s-1 Mdm2 is degraded at higher rate 
after phosphorylation by 
ATM[21].
23 p53_mRNA synthesis GO:0009299 ksynp53mRNA 1.0E-3 mol s-1 Assume turnover of mRNA is 
about 2 hours
24 p53_mRNA degradation GO:0006402 kdegp53mRNA<#p53_mRNA> 1.0E-4 s-1
aReaction numbers correspond to the numbered arrows in Figures 3 and 9, bmol refers to the number of moleculesBMC Systems Biology 2008, 2:75 http://www.biomedcentral.com/1752-0509/2/75
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SBML and imported into the BASIS modelling environ-
ment using web-services [57]. Simulations were carried
out using the stochastic simulator which is based on the
Gillespie algorithm [58]. The SBML code can be accessed
by the reader [see Additional file 1 for the ARF model and
Additional file 2 for the ATM model]. The models are also
available in the public space of BASIS (ARF model:
urn:basis.ncl:model:4770; ATM model:
urn:basis.ncl:model:4775) and the Biomodels database
[54,59] [ARF Model:MODEL:8142536273, ATM model:
MODEL:5836973167] and can be freely accessed by the
reader. Repeat simulations were carried out to investigate
the variability in the model output. The model output was
exported from BASIS to the R statistical package, an open-
source software application, and the results were analysed
and plotted. The autocorrelation function was also plot-
ted for each result to confirm whether the oscillations
were distinct from white noise. The deterministic simula-
tions were performed in Mathematica using MathSBML
[60].
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